health
Study links blood RNA marker to ovarian cancer precursor detection
A study in Nature Medicine assessed the RNA marker Tu-stroma in serum extracellular vesicles from 506 people, including people with STIC and high-grade serous ovarian cancer. The researchers report strong separation from control and benign-lesion groups, with prospective testing still needed to assess clinical use.